Envía por correo este artículo 
Aminotransferasas y perfil lipídico en pacientes con dengue
Resumen
Estudios previos evidencian un incremento de los casos de Dengue que cursan con un cuadro de disfunción hepática, lo que amerita estudios que evalúen el mecanismo de afección hepática en relación al serotipo infectante. Así mismo, las lipoproteínas pueden tener la capacidad de modificar la función de la respuesta inflamatoria y de esta manera alterar la respuesta inmunitaria del hospedero durante las infecciones. Se ha sugerido que una disminución en las concentraciones de C-HDL y C-LDL, así como alteraciones en los niveles de colesterol total y triglicéridos plasmáticos en los pacientes infectados por virus Dengue desarrollan las formas más severas de la enfermedad, sin embargo, no se ha relacionado al serotipo viral infectante.
Palabras clave
Referencias
(1) Kyle, J.L., Harris, E. 2008. Global spread and persistence of dengue. Annual Review of Microbiology 62, 71–92.
(2) Guzmán, M.G., Halstead, S.B., Artsob, H., Buchy, P., Farrar, J., Gubler, D.J., Hunsperger, E., Kroeger, A., Margolis, H.S., Martínez, E., Nathan, M.B., Pelegrino, J.L., Simmons, C., Yoksan, S., Peeling, R.W. 2010. Dengue: a continuing global threat. Nature Reviews Microbiology 8, S7–S16.
(3) Normile, D. 2013. Surprising New Dengue Virus Throws A Spanner in Disease Control Efforts. Science; 342:415.
(4) Organización Mundial de la Salud. [Fecha de consulta: 19/03/2011]. Disponible en: http://whqlibdoc.who.int/publications/ 2009/9789241547871_eng.pdf
(5) PAHO, Health Information Platform, 2018) disponible en: http://www.paho.org/data/index.php/en/mnu-topics/indicadores-dengue-en/dengue-nacional-en/252-dengue-pais-ano-en.html?showall=&start=1)
(6) Ramos-Castañeda J, Barreto dos Santos F, Martìnez-Vega R, Galvão de Araujo JM, Joint G, Sarti E (2017) Dengue in Latin America: Systematic Review of Molecular Epidemiological Trends. PLoS Negl Trop Dis 11(1): e0005224. doi:10.1371/ journal.pntd.0005224.
(7) Sun, X., Whittaker, G.R. 2003. Role for influenza virus envelope cholesterol in virus entry and infection. Journal of Virology 77, 12543–12551.
(8) Imhoff, H., von Messling, V., Herrler, G., Haas, L. 2007. Canine distemper virus infection requires cholesterol in the viral envelope. Journal of Virology 81, 4158–4165.
(9) Bremer, C.M., Bung, C., Kott, N., Hardt, M., Glebe, D. 2009. Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cellular Microbiology 11, 249–260.
(10) Lu, X., Xiong, Y., Silver, J. 2002. Asymmetric requirement for cholesterol in receptorbearing but not envelope-bearing membranes for fusion mediated by ecotropic murine leukemia virus. Journal of Virology 76, 6701–6709.
(11) Bavari, S., Bosio, C.M., Wiegand, E., Ruthel, G., Will, A.B., Geisbert, T.W., Hevey, M., Schmaljohn, C., Schmaljohn, A., Aman, M.J. 2002. Lipid raft microdomains: agateway for compartmentalized trafficking of Ebola and Marburg viruses. Journal of Experimental Medicine 195, 593–602.
(12) Liao, Z., Cimakasky, L.M., Hampton, R., Nguyen, D.H., Hildreth, J.E. 2001. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Research and Human Retroviruses 17, 1009–1019.
(13) Graham, D.R., Chertova, E., Hilburn, J.M., Arthur, L.O., Hildreth, J.E. 2003. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. Journal of Virology 77, 8237–8248.
(14) Ren, X., Glende, J., Yin, J., Schwegmann-Wessels, C., Herrler, G. 2008. Importance of cholesterol for infection of cells by transmissible gastroenteritis virus. Virus Research 137, 220–224.
(15) Yin, J., Glende, J., Schwegmann-Wessels, C., Enjuanes, L., Herrler, G., Ren, X. 2010. Cholesterol is important for a post-adsorption step in the entry process of transmisible gastroenteritis virus. Antiviral Research 88, 311–316.
(16) Clemente, R., de Parseval, A., Perez, M., de la Torre, J.C. 2009. Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient virus entry. Journal of Virology 83, 2655–2662.
(17) Bender, F.C., Whitbeck, J.C., Ponce, D.L., Lou, H., Eisenberg, R.J., Cohen, G.H. 2003. Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. Journal of Virology 77, 9542–9552.
(18) Desplanques, A.S., Nauwynck, N.J., Vercauteren, D. Geens, T., Favoreel, H.W. 2008. Plasma membrane cholesterol is required for efficient pseudorabies virus entry. Virology 376, 339–345.
(19) Desplanques, A.S., Pontes, M., De Corte, N., Verheyen, N., Nauwynck, N.J. Vercauteren, D., Favoreel, H.W. 2010. Cholesterol depletion affects infectivity and stability of pseudorabies virus. Virus Research 152, 180–183.
(20) Hambleton, S., Steinberg, S.P., Gershon, M.D., Gershon, A.A. 2007. Cholesterol dependence of varicella-zoster virion entry into target cells. Journal of Virology 81, 7548–7558.
(21) Thorp, E.B., Gallagher, T.M. 2004. Requirements for CEACAMs and cholesterol during murine coronavirus cell entry. Journal of Virology 78, 2682–2692.
(22) Acosta, E.G., Castilla, V., Damonte, E.B. 2008. Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocitosis. Journal of General Virology 89, 474–484.
(23) Acosta, E.G., Castilla, V., Damonte, E.B. 2011. Infectious dengue-1 virus entry into mosquito C6/36 cells. Virus Research 160, 173–179.
(24) Mosso, C, Galván-Mendoza, I.J, Ludert, J.E, del Angel, R.M. 2008. Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT. Virology 378, 193–199.
(25) Acosta, E.G., Castilla, V., Damonte, E.B. 2009. Alternative infectious entry pathways for dengue virus serotypes into mammalian cells. Cellular Microbiology 11, 1533–1549.
(26) Peng, T., Wang, J.L., Chen, W., Zhang, J.L., Gao, N., Chen, Z.T., Xu, X.F., Fan, D.Y., An, J. 2009. Entry of dengue virus serotype 2 into ECV304 cells depends on clathrindependent endocytosis, but not on caveolae-dependent endocytosis. Canadian Journal of Microbiology 55, 139–145.
(27) İlhan ÇETİN, Beytullah YILDIRIM, Şemsettin ŞAHİN, İdris ŞAHİN, İlker ETİKAN. Serum lipid and lipoprotein levels, dyslipidemia prevalence, and the factors that influence these parameters in a Turkish population living in the province of Toka. Turk J Med Sci. 2010; 40 (5): 771-782.
(28) Aguilar Salinas C, Francisco Javier Gómez Pérez,* Israel Lerman Garber, Cuauhtémoc Vázquez Chávez, Óscar Pérez Méndez, Carlos Posadas Romero. Diagnóstico y tratamiento de las dislipidemias: posición de la Sociedad Mexicana de Nutrición y Endocrinología. Revista de Endocrinología y Nutrición Vol. 12, No. 1 Enero-Marzo 2004 pp 7-41.
(29) Freire W. La Nueva Situación Epidemiológica en el Ecuador. Revista Informativa OPS/OMS Edición 32, 2014.
(30) Ray G, Kumar V, Kapoor AK, Dutta AK, Batra S, 1999. Status of antioxidants and other biochemical abnormalities in children with dengue fever. J Trop Pediatr 45: 4–7.
Feingold KR, Hardardottir I, Grunfeld C. 1998. Beneficial effects of cytokine induced hyperlipidemia. Z Ernahrungswiss 37(Suppl 1):66–74.
(32) Durán A, Bermúdez J, Maldonado MB, Ochoa E, Alcocer S, Levy A, Márquez A, Bermúdez I, Gómez M, Gotera J, Valero N. 2012. Incidencia y circulación del virus dengue en el Estado Zulia, Venezuela (2009-2010). Revista Ciencia 20(1):22-32.
(33) Alvarez ME, Ramirez-Ronda CH. 1985. Dengue and hepatic failure. Am J Med 79: 670-674.
(34) Torres MC, Mujica AA, Valero, N. Castillo, J, Mosquera, J, Pons, H. Dengue nonstructural protein-1 is not associated to circulating levels of IL-17, PCR and complement in children with acute dengue. J Clin Virol.2013; 56; 199-206.
(35) Krippner R, Hanish G, Kretschmer H. 1990. Dengue fever with hemorrhagic manifestations after a stay in Thailand. Dtsch Med Wochenschr 115: 858–862.
(36) Wang X, Diaz A, Hao L, Gancarz B, den Boon JA, Ahlquist P. 2011. Intersection of the multivesicular body pathway and lipid homeostasis in RNA replication by a positive-strand RNA virus. J Virol 85: 5494–50.
(37) Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. 1992. Liver biochemical tests and dengue fever. Am J Trop Med Hyg 47: 265–270.
(38) Monath TP. 1997. Early indicators in acute dengue infection. Lancet 350: 1719–1720.
(39) Nguyen TL, Nguyen TH, Tieu NT. 1997. The impact of dengue hemorrhagic fever on liver function. Res Virol 148: 273–277.
(40) Alvisi G, Madan V, Bartenschlager R. 2011. Hepatitis C virus and host cell lipids: an intimate connection. RNA Biol 8: 258–6.
(41) Larreal Y, Espina LM, Andrade E, Cuevas Y, Mendoza A, Montiel M, Levy A, Valero N. 2012. Pruebas de funcionalismo hepático en pacientes con infección viral aguda. Acta bioquím. clín. latinoam. vol.46, n.1, pp. 38-46.
(42) Gaceta Epidemiológica del año 2017. SIVEALERTA SE 52. Ministerio de Salud Publica, Ecuador.
(43) Dengue guidelines for diagnosis, treatment, prevention and control, 3rd edn. 2009. World Health Organization, Geneva. http:// www.who.int/tdr/publications/documents/dengue-diagnosis.pdf
(44) CDC Zika laboratory guidance and testing algorithm may be found on CDC’s website: http://www.cdc.gov/zika/laboratories/lab-guidance.html
(45) Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol. 1992 Mar; 30(3):545-51.
(46) Friedewald WT, Levi, RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499-502.
(47) The National Cholesterol Education Program. NCEP 2001. https://www.nhlbi.nih.gov/files/docs/guidelines/atglance.pdf
(48) Suvarna J.C, Rane P.P. 2009. Serum lipid profile: a predictor of clinical outcome in dengue infection. Tropical Medicine and International Health. volume 14 no 5 pp 576–585
(49) Iribarren, C., Jacobs, DR., Sidney, S., Feingold, KR. 1998. Cohort study of serum total cholesterol and in-hospital incidence of Infectious diseases. Epidemiology and Infection; 121: 335-347.
(50) Larreal Y, Valero N, Estévez J, Reyes I, Maldonado M, Espina L, Arias J, Meleán E, Añez G, Atencio R. 2005. Alteraciones hepáticas en pacientes con dengue. Invest Clín; 46: 169-78.
(51) Spencer CM, Schafer XL, Moorman NJ, Munger J. 2011. Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J Virol 85: 5814–24.
(52) Palmira Pramparo, Carlos Boissonnet, Herman Schargrodsky, por los Investigadores del estudio CARMELA. Evaluación del riesgo cardiovascular en siete ciudades de Latinoamérica: las principales conclusiones del estudio CARMELA y de los subestudios. Revista Argentina de Cardiología / Vol 79 Nº 4 / Julio-Agosto 201.
(53) Valero N, Reyes I, Larreal Y, Maldonado M. Aminotransferasas séricas en pacientes con Dengue tipo 3. Rev Méd Chile 2007; 135: 1304-1312.
(54) Durán A, Carrero R, Parra B, González A, Delgado L, Mosquera J, Valero N. Association of lipid profile alterations with severe forms of dengue in humans. Arch Virol. 2015;160(7):1687-92. doi: 10.1007/s00705-015-2433-z.
(55) Salgado D, Acosta Ortiz H, Bayona Ospina M, Rodríguez Rodríguez J, Narváez C, Villar Centeno L, Zabaleta Salazar T. Compromiso Hepático por dengue en niños de Huila, Colombia. Rev. salud pública, Volumen 14, Número 6, p. 978-988, 2012. ISSN electrónico 2539-3596. ISSN impreso 0124-0064.
DOI: https://doi.org/10.23857/pc.v4i10.1162
Enlaces de Referencia
- Por el momento, no existen enlaces de referencia
Polo del Conocimiento
Revista Científico-Académica Multidisciplinaria
ISSN: 2550-682X
Casa Editora del Polo
Manta - Ecuador
Dirección: Ciudadela El Palmar, II Etapa, Manta - Manabí - Ecuador.
Código Postal: 130801
Teléfonos: 056051775/0991871420
Email: polodelconocimientorevista@gmail.com / director@polodelconocimiento.com
URL: https://www.polodelconocimiento.com/
